149.92
Krystal Biotech Inc Stock (KRYS) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
7.37%
45.25
|
42.14 | 8.556 | - | - |
|
33.15%
51.93
|
39.01 | 34.55 | 38.05 | 48.82 |
Benefits Costs and Expenses |
100.00%
-
|
37.80 | - | - | - |
Costs And Expenses |
162.11%
51.93
|
-83.62 | 34.55 | - | - |
Operating Income/Loss |
313.00%
-6.684
|
3.138 | -25.99 | -38.05 | -48.82 |
Income/Loss From Continuing Operations Before Tax |
942.39%
45.25
|
4.341 | 8.556 | -33.21 | -45.30 |
Income/Loss From Continuing Operations After Tax |
89.28%
0.932
|
8.692 | 80.75 | -33.21 | -45.30 |
|
89.28%
0.932
|
8.692 | 80.75 | -33.21 | -45.30 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
8,176%
28.30
|
0.3419 | 28.04 | 26.66 | 25.71 |
Diluted Average Shares |
7,875%
29.29
|
0.3673 | 28.89 | 26.66 | 25.71 |
Basic Earnings Per Share |
90.63%
0.03
|
0.32 | 2.88 | -1.25 | -1.76 |
Diluted Earnings Per Share |
90.32%
0.03
|
0.31 | 2.79 | -1.25 | -1.76 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):